Once again, Novo and Lilly are providing studies that don't begin to address real life-and-death concerns as they market the hell out of these meds. I wish your analyses of these studies were broadcast far and wide to counteract the outsized media hype these meds are getting.
I saw a pain doctor last week for five minutes to discuss a cortisone injection in my lumbar region. Two minutes into the appointment he asked if I was taking Mounjaro, "the GLP with the best reported results." I told him no. When he asked why I said it was complicated, as I wanted to shut down this conversation without having my blood pressure go through the roof. He backed off. But how the hell does he think it's at all appropriate to bring up weight loss in this context?
Needless to say, I left there with a very low opinion of this MD, who, in a couple of weeks, is going to stick big needles in my spine,
I’ve noticed that my allergy and asthma pills don’t work half as well if I take an acid reducer of some kind within an hour… I can’t imagine how bad off I’d be if I were taking it on top of one of these GLP1’s.
So now in 5-10 years, when we see that people on weight-loss-level doses of these meds are dying early of preventable things related to blood pressure, blood sugar, asthma, heart disease, seizures, (the list goes on), I bet that means the headlines will say we were simply too fat to be helped and died of our fatness, so we better start putting people on these drugs younger and sooner!
Sadly jen I think you're right, especially if we look at weight loss surgeries. How often are deaths that could just as easily be due to these surgeries attributed to fatness instead?
Hm, do you think this is related to the "Ozempic pregnancy" headlines? I admit I haven't read any of those articles because I don't care, but I sort of thought they were about situations where weight loss positively affects fertility. But maybe they were about how oral contraceptives don't work right with GLP-1 meds.
Once again, Novo and Lilly are providing studies that don't begin to address real life-and-death concerns as they market the hell out of these meds. I wish your analyses of these studies were broadcast far and wide to counteract the outsized media hype these meds are getting.
I saw a pain doctor last week for five minutes to discuss a cortisone injection in my lumbar region. Two minutes into the appointment he asked if I was taking Mounjaro, "the GLP with the best reported results." I told him no. When he asked why I said it was complicated, as I wanted to shut down this conversation without having my blood pressure go through the roof. He backed off. But how the hell does he think it's at all appropriate to bring up weight loss in this context?
Needless to say, I left there with a very low opinion of this MD, who, in a couple of weeks, is going to stick big needles in my spine,
Ragen, thanks for the great work, as always.
The old "weight loss cures back pain" trope 🤬
Oh damn, this is so disappointing.
I’ve noticed that my allergy and asthma pills don’t work half as well if I take an acid reducer of some kind within an hour… I can’t imagine how bad off I’d be if I were taking it on top of one of these GLP1’s.
So now in 5-10 years, when we see that people on weight-loss-level doses of these meds are dying early of preventable things related to blood pressure, blood sugar, asthma, heart disease, seizures, (the list goes on), I bet that means the headlines will say we were simply too fat to be helped and died of our fatness, so we better start putting people on these drugs younger and sooner!
Sadly jen I think you're right, especially if we look at weight loss surgeries. How often are deaths that could just as easily be due to these surgeries attributed to fatness instead?
Hm, do you think this is related to the "Ozempic pregnancy" headlines? I admit I haven't read any of those articles because I don't care, but I sort of thought they were about situations where weight loss positively affects fertility. But maybe they were about how oral contraceptives don't work right with GLP-1 meds.